Charles Sternberg, Associate Editor02.25.22
BlackHägen Design’s founder, Sean Hägen and industrial designers Bartosz Korec and James Brown, have been named contributors on a multi-country medical device patent involving an innovative auto-injector design.
In conjunction with the BlackHägen designers, medical device developer PreciHealth designed a solution for self-vaccination and remote medical treatment. This miniaturized auto-injector technology permits different volumetric capabilities ranging from 25 mm3 to 2,500 mm3. These smaller, user-friendly devices are easier to carry and have been developed for simple and safe administration. Their small size helps facilitate seamless integration with other platforms such as robotics, microsurgery tools and endoscopes, telemedicine IoT, and veterinary applications.
"During our collaboration with BlackHägen Design, we were impressed with their fast reaction time and user-centered methodologies. They succeeded in addressing the constraints of the complex inside mechanism of our device while ensuring its ease of use for the patient," said Alain Jaccard, chief innovation officer at PreciHealth.
Receiving approval on this patent from several countries (Europe, Switzerland, Japan, China, and patent pending in the U.S.), supports the BlackHägen global objective to be an instrumental design research and usability design partner for its customers in medical device, healthcare, and pharmaceutical industries.
“We were excited receiving the news of this patent approval, as it validates and protects the uniqueness of the design, a key differentiator for our client. The power of user-centric design and engineering techniques was instrumental in developing this auto-injector,” said Sean Hägen, BlackHägen Design principal, founder and director of Research and Synthesis.
A strategic patent portfolio can be crucial for a medical device company’s growth and survival and can help secure funding, which is vital for bringing new products to market.
In addition to this patent, another utility patent was recently filed by PreciHealth, naming Bartosz Korec, Philip Remedios, and Sean Hägen also as co-inventors: International patent application PCT/IB2021/000187: WO2021198768 – Body Fluids Sampling Device and Method of Using the Same.
In conjunction with the BlackHägen designers, medical device developer PreciHealth designed a solution for self-vaccination and remote medical treatment. This miniaturized auto-injector technology permits different volumetric capabilities ranging from 25 mm3 to 2,500 mm3. These smaller, user-friendly devices are easier to carry and have been developed for simple and safe administration. Their small size helps facilitate seamless integration with other platforms such as robotics, microsurgery tools and endoscopes, telemedicine IoT, and veterinary applications.
"During our collaboration with BlackHägen Design, we were impressed with their fast reaction time and user-centered methodologies. They succeeded in addressing the constraints of the complex inside mechanism of our device while ensuring its ease of use for the patient," said Alain Jaccard, chief innovation officer at PreciHealth.
Receiving approval on this patent from several countries (Europe, Switzerland, Japan, China, and patent pending in the U.S.), supports the BlackHägen global objective to be an instrumental design research and usability design partner for its customers in medical device, healthcare, and pharmaceutical industries.
“We were excited receiving the news of this patent approval, as it validates and protects the uniqueness of the design, a key differentiator for our client. The power of user-centric design and engineering techniques was instrumental in developing this auto-injector,” said Sean Hägen, BlackHägen Design principal, founder and director of Research and Synthesis.
A strategic patent portfolio can be crucial for a medical device company’s growth and survival and can help secure funding, which is vital for bringing new products to market.
In addition to this patent, another utility patent was recently filed by PreciHealth, naming Bartosz Korec, Philip Remedios, and Sean Hägen also as co-inventors: International patent application PCT/IB2021/000187: WO2021198768 – Body Fluids Sampling Device and Method of Using the Same.